
CMXC
Healthcare · Medical Devices · $126.3M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 15, 2024 | Before the open | — | -0.00 | — |
| Aug 30, 2024 | After the close | — | -0.00 | — |
| Apr 15, 2024 | After the close | — | 0.00 | — |
| Apr 7, 2023 | Time not confirmed | — | -0.00 | — |
| Apr 11, 2022 | Time not confirmed | — | -0.00 | — |
| Jan 12, 2022 | Time not confirmed | — | -0.00 | — |
| Oct 14, 2021 | Time not confirmed | — | -0.00 | — |
| Aug 30, 2021 | Time not confirmed | — | -0.02 | — |
| Apr 9, 2021 | Time not confirmed | — | -0.01 | — |
| Jan 14, 2021 | Time not confirmed | — | -0.00 | — |
| Sep 15, 2020 | Time not confirmed | — | -0.00 | — |
| Aug 31, 2020 | Time not confirmed | — | -0.00 | — |
| Apr 14, 2020 | Time not confirmed | — | -0.01 | — |
| Jan 14, 2020 |
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for…
| Time not confirmed |
| — |
| -0.01 |
| — |
| Sep 6, 2019 | Time not confirmed | — | -0.01 | — |
| Aug 31, 2019 | Time not confirmed | — | -0.01 | — |
| Apr 22, 2019 | Time not confirmed | — | -0.01 | — |
| Jan 14, 2019 | Time not confirmed | — | -0.01 | — |
| Sep 13, 2018 | Time not confirmed | — | -0.01 | — |
| Aug 31, 2018 | Time not confirmed | — | -0.01 | — |
| Apr 16, 2018 | Time not confirmed | — | -0.01 | — |
| Jan 16, 2018 | Time not confirmed | — | -0.01 | — |